{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:33Z","timestamp":1792787853455,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404376"],"award-info":[{"award-number":["82404376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Scientific Research Foundation of Guangdong Province in China","award":["A2024152"],"award-info":[{"award-number":["A2024152"]}]},{"name":"Young Innovative Talents Project of General Universities in Guangdong Province in China","award":["2023KQNCX023"],"award-info":[{"award-number":["2023KQNCX023"]}]},{"name":"Funds for Researcher of Guangdong Medical University in China","award":["GDMUB2023025"],"award-info":[{"award-number":["GDMUB2023025"]}],"id":[{"id":"https:\/\/ror.org\/04k5rxe29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-29368-9","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:18:20Z","timestamp":1788823100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographic and temporal variations in cancer incidence attributable to human papillomavirus infection in China: a population-based study"],"prefix":"10.1186","volume":"26","author":[{"given":"Junli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-1872","authenticated-orcid":false,"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"2","key":"29368_CR1","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Global Health. 2020;8(2):e180\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(19)30488-7.","journal-title":"Lancet Global Health"},{"key":"29368_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","volume":"772","author":"ME Harden","year":"2017","unstructured":"Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res Rev Mutat Res. 2017;772:3\u201312. https:\/\/doi.org\/10.1016\/j.mrrev.2016.07.002.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"10451","key":"29368_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024;404(10451):435\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(24)01097-3.","journal-title":"Lancet"},{"key":"29368_CR4","unstructured":"National Health Commission of China. Notice from the Ministry of Health and the All. China Women\u2019s Federation on Issuing the Management Plan for the Two Cancer Examination Projects for Rural Women. Available from: https:\/\/www.nhc.gov.cn\/zwgk\/wtwj\/201304\/72fcd32b37a14fa59460dd267febe6d8.shtml. Accessed 19 Jan 2026."},{"key":"29368_CR5","unstructured":"National Health Commission of China. HPV vaccine becomes available in China for women ages 16 to 26. Available from: https:\/\/en.nhc.gov.cn\/2018-04\/29\/c_73354.htm. Accessed 19 Jan 2026."},{"key":"29368_CR6","unstructured":"Notice on Matters Concerning the Inclusion of Human Papillomavirus Vaccine in the National Immunization Program. Available from: https:\/\/www.gov.cn\/zhengce\/zhengceku\/202510\/content_7046467.htm. Accessed 19 Jan 2026."},{"issue":"16","key":"29368_CR7","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/cncr.32986","volume":"126","author":"Y Lu","year":"2020","unstructured":"Lu Y, Li P, Luo G, Liu D, Zou H. Cancer attributable to human papillomavirus infection in China: Burden and trends. Cancer. 2020;126(16):3719\u201332. https:\/\/doi.org\/10.1002\/cncr.32986.","journal-title":"Cancer"},{"key":"29368_CR8","doi-asserted-by":"publisher","unstructured":"Tian T, Fu L, Li Y, Yong L, Lu Z, He J, Yu W, Asilibek SL, Zhang Z, Zhen C et al. Global trends in the incidence of cancer attributable to human papillomavirus infection: A population-based study. Int J Cancer 2025;157(8):1590\u201399. https:\/\/doi.org\/10.1002\/ijc.35520.","DOI":"10.1002\/ijc.35520"},{"key":"29368_CR9","unstructured":"Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents Volume VII. IARC Scientific Publications, No. 143, Lyon, IARC; 1997."},{"key":"29368_CR10","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents Volume VIII. IARC Scientific Publications, No. 155, Lyon, IARC; 2002."},{"key":"29368_CR11","unstructured":"Curado MP, EB, Shin HR, Storm H, Heanue FJ. M. and, Boyle P. Cancer Incidence in Five Continents Volume IX. IARC Scientific Publications, No. 160, Lyon, IARC; 2007."},{"key":"29368_CR12","volume-title":"Cancer Incidence in Five Continents, Vol. X. IARC Scientific Publication No. 164","author":"DBF Forman","year":"2014","unstructured":"Forman DBF, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer Incidence in Five Continents Vol. X. IARC Scientific Publication No. 164. Lyon,IARC; 2014."},{"key":"29368_CR13","unstructured":"Bray F CM, Mery L, Pi\u00f1eros M, Znaor A, Zanetti R and Ferlay J. Cancer Incidence in Five Continents. Vol. XI (electronic version). Available from: https:\/\/ci5.iarc.who.int.\u00a0Accessed 19 Jan 2026."},{"key":"29368_CR14","unstructured":"Bray F CM, Aitken JF, Bardot A, Eser S, Galceran J, Hagenimana M, Matsuda T, Mery L, Pi\u00f1eros M, Soerjomataram I, de Vries E, Wiggins C, Won Y-J, Znaor A, and Ferlay J. Cancer Incidence in Five Continents. Vol. XII (IARC CancerBase No. 19). Available from: https:\/\/ci5.iarc.who.int. Accessed\u00a0 19 Jan 2026."},{"key":"29368_CR15","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2022). World Population Prospects 2022: Summary of Results; 2022."},{"key":"29368_CR16","doi-asserted-by":"publisher","unstructured":"Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagu\u00e9 X, Laporte L, Bosch FX, de Sanjos\u00e9 S, Trottier H. HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(14)70471-1.","DOI":"10.1016\/S1470-2045(14)70471-1"},{"key":"29368_CR17","doi-asserted-by":"publisher","unstructured":"de Sanjos\u00e9 S, Serrano B, Tous S, Alejo M, Lloveras B, Quir\u00f3s B, Clavero O, Vidal A, Ferr\u00e1ndiz-Pulido C, Pav\u00f3n M et al. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58. JNCI Cancer Spectr. 2019; 2(4):pky045. https:\/\/doi.org\/10.1093\/jncics\/pky045.","DOI":"10.1093\/jncics\/pky045"},{"issue":"11","key":"29368_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"9","key":"29368_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","volume":"127","author":"J Lau","year":"1997","unstructured":"Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820\u20136. https:\/\/doi.org\/10.7326\/0003-4819-127-9-199711010-00008.","journal-title":"Ann Intern Med"},{"key":"29368_CR20","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021."},{"key":"29368_CR21","volume-title":"Cancer mortality for selected sites in 24 countries (1950\u201357)","author":"M Segi","year":"1960","unstructured":"Segi M. Cancer mortality for selected sites in 24 countries (1950\u201357). Sendai, Japan: Department of Public Health, Tohoku University of Medicine; 1960."},{"key":"29368_CR22","doi-asserted-by":"crossref","unstructured":"Doll R, Payne P, Waterhouse J. Cancer Incidence in Five Continents: A Technical Report. International Union against Cancer; 1966.","DOI":"10.1007\/978-3-642-85849-9"},{"issue":"5","key":"29368_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3961\/jpmph.24.272","volume":"57","author":"S Lee","year":"2024","unstructured":"Lee S, Moon S, Kim K, Sung S, Hong Y, Lim W, Park SK. A Comparison of Green, Delta, and Monte Carlo Methods to Select an Optimal Approach for Calculating the 95% Confidence Interval of the Population-attributable Fraction: Guidance for Epidemiological Research. J Prev Med Public Health. 2024;57(5):499\u2013507. https:\/\/doi.org\/10.3961\/jpmph.24.272.","journal-title":"J Prev Med Public Health"},{"key":"29368_CR24","unstructured":"National Bureau of Statistics of China. China Statistical Yearbook 2016. China Statisties Press; 2016."},{"key":"29368_CR25","doi-asserted-by":"publisher","unstructured":"Kim HJ. Fay Mp Fau - Feuer EJ, Feuer Ej Fau - Midthune DN, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3C;335::aid-sim336%3E;3.0.co;2-z.","DOI":"10.1002\/(sici)1097-0258(20000215)19:3%3C;335::aid-sim336%3E;3.0.co;2-z"},{"issue":"3","key":"29368_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/thy.2024.0583","volume":"35","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Liu J, Hu J, Zhang Y. The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study. Thyroid. 2025;35(3):307\u201320. https:\/\/doi.org\/10.1089\/thy.2024.0583.","journal-title":"Thyroid"},{"issue":"2","key":"29368_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","volume":"71","author":"H Rue","year":"2009","unstructured":"Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B (Statistical Methodology). 2009;71(2):319\u201392. https:\/\/doi.org\/10.1111\/j.1467-9868.2008.00700.x.","journal-title":"Journal of the Royal Statistical Society Series B (Statistical Methodology)"},{"key":"29368_CR28","doi-asserted-by":"publisher","unstructured":"Rue H, Riebler A, S\u00f8rbye SH, Illian JB, Simpson DP, Lindgren FK. Bayesian Computing with INLA: A Review. Ann Rev Statis Appl. 2017;4:395\u2013421. https:\/\/doi.org\/10.1146\/annurev-statistics-060116-054045.","DOI":"10.1146\/annurev-statistics-060116-054045"},{"issue":"1","key":"29368_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12874-022-01626-5","volume":"22","author":"S Yap","year":"2022","unstructured":"Yap S, Luo Q, Wade S, Weber M, Banks E, Canfell K, O\u2019Connell DL, Steinberg J. Raking of data from a large Australian cohort study improves generalisability of estimates of prevalence of health and behaviour characteristics and cancer incidence. BMC Med Res Methodol. 2022;22(1):140. https:\/\/doi.org\/10.1186\/s12874-022-01626-5.","journal-title":"BMC Med Res Methodol"},{"key":"29368_CR30","unstructured":"Ferlay J, Colombet M and Bray F. Cancer Incidenc in Five Continents, CI5plus: IARC CancerBase No. 9 Available from: https:\/\/ci5.iarc.who.int. Accessed\u00a0 19 Jan 2026."},{"key":"29368_CR31","unstructured":"Surveillance Research Program, National Cancer Institute. Joinpoint Regression Software, Version 5.4.0. 2025. Available from: https:\/\/surveillance.cancer.gov\/joinpoint."},{"key":"29368_CR32","volume-title":"R: A Language and Environment for Statistical Computing","author":"RC Team","year":"2025","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria. 2025. Available from: https:\/\/www.R-project.org\/."},{"issue":"33","key":"29368_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","volume":"68","author":"V Senkomago","year":"2019","unstructured":"Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human Papillomavirus-Attributable Cancers - United States, 2012\u20132016. MMWR Morb Mortal Wkly Rep. 2019;68(33):724\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6833a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"29368_CR34","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/jco.2015.61.6995","volume":"33","author":"ML Gillison","year":"2015","unstructured":"Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33(29):3235\u201342. https:\/\/doi.org\/10.1200\/jco.2015.61.6995.","journal-title":"J Clin Oncol"},{"issue":"5","key":"29368_CR35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1158\/1055-9965.Epi-21-1124","volume":"31","author":"R Duan","year":"2022","unstructured":"Duan R, Xu K, Huang L, Yuan M, Wang H, Qiao Y, Zhao F. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007\u20132030. Cancer Epidemiol Biomarkers Prev. 2022;31(5):1130\u20136. https:\/\/doi.org\/10.1158\/1055-9965.Epi-21-1124.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"29368_CR36","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/s1470-2045(20)30073-5","volume":"21","author":"W Wei","year":"2020","unstructured":"Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, Wang S, Sun K, Matsuda T, Bray F, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21(7):e342\u20139. https:\/\/doi.org\/10.1016\/s1470-2045(20)30073-5.","journal-title":"Lancet Oncol"},{"issue":"9","key":"29368_CR37","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ijc.29670","volume":"137","author":"F Bray","year":"2015","unstructured":"Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, Steliarova-Foucher E, Swaminathan R, Antoni S, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060\u201371. https:\/\/doi.org\/10.1002\/ijc.29670.","journal-title":"Int J Cancer"},{"issue":"12","key":"29368_CR38","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/ijc.34885","volume":"154","author":"S Shivshankar","year":"2024","unstructured":"Shivshankar S, Mhamane S, Budukh AM. Representation of Indian and Chinese cancer registries from 1964 to 2017 in Cancer Incidence in Five Continents: Growing burden but low coverage. Int J Cancer. 2024;154(12):2200\u20133. https:\/\/doi.org\/10.1002\/ijc.34885.","journal-title":"Int J Cancer"},{"issue":"06","key":"29368_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3877\/cma.j.issn.2095-3224.2024.06.001","volume":"13","author":"Anti-Cancer Association China, Committee of Colorectal Cancer CACA.","year":"2024","unstructured":"Anti-Cancer Association China, Committee of Colorectal Cancer CACA. CACA guidelines for holistic integrative management of anal cancer (2024 Edition). Chin J Colorectal Dis (Electronic Edition). 2024;13(06):441\u20139. https:\/\/doi.org\/10.3877\/cma.j.issn.2095-3224.2024.06.001.","journal-title":"Chin J Colorectal Dis (Electronic Edition)"},{"issue":"17","key":"29368_CR40","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/cncr.33628","volume":"127","author":"J Wu","year":"2021","unstructured":"Wu J, Xiao F, Zheng Y, Lin Y, Wang HL. Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030. Cancer. 2021;127(17):3172\u201382. https:\/\/doi.org\/10.1002\/cncr.33628.","journal-title":"Cancer"},{"issue":"10","key":"29368_CR41","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/ijc.33055","volume":"147","author":"F Bray","year":"2020","unstructured":"Bray F, Laversanne M, Weiderpass E, Arbyn M. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer. 2020;147(10):2764\u201371. https:\/\/doi.org\/10.1002\/ijc.33055.","journal-title":"Int J Cancer"},{"issue":"9","key":"29368_CR42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3760\/cma.j.cn112338-20250526-00348","volume":"46","author":"CHPE Association","year":"2025","unstructured":"China Health Promotion and Education Association. Expert consensus on preventive strategies for human papillomavirus-associated diseases in males. Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46(9):1519\u201330. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20250526-00348.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"29368_CR43","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.ijgc.2024.100007","volume":"35","author":"M Preti","year":"2025","unstructured":"Preti M, Lewis F, Carcopino X, Bevilacqua F, Ellis LB, Halonen P, Hemida R, Jach R, Kesic V, Kyrgiou M, et al. Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statements. Int J Gynecol Cancer. 2025;35(1):100007. https:\/\/doi.org\/10.1016\/j.ijgc.2024.100007.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"29368_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41571-024-00904-z","volume":"21","author":"T Malag\u00f3n","year":"2024","unstructured":"Malag\u00f3n T, Franco EL, Tejada R, Vaccarella S. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 2024;21(7):522\u201338. https:\/\/doi.org\/10.1038\/s41571-024-00904-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"29368_CR45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306\u201327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"29368_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/s1470-2045(24)00189-x","volume":"25","author":"F Jin","year":"2024","unstructured":"Jin F, Vajdic CM, Poynten IM, McGee-Avila JK, Castle PE, Grulich AE. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis. Lancet Oncol. 2024;25(7):933\u201344. https:\/\/doi.org\/10.1016\/s1470-2045(24)00189-x.","journal-title":"Lancet Oncol"},{"key":"29368_CR47","doi-asserted-by":"publisher","unstructured":"Xia C, Li H, Wu C, Chen W. Cancer burden and control in China: landscape, trends and challenges. Nat Rev Clin Oncol. 2026;23(9):694\u2013711. https:\/\/doi.org\/10.1038\/s41571-026-01165-8.","DOI":"10.1038\/s41571-026-01165-8"},{"issue":"4","key":"29368_CR48","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jnci\/djae298","volume":"117","author":"F Alarid-Escudero","year":"2025","unstructured":"Alarid-Escudero F, Gracia V, Wolf M, Zhao R, Easterly CW, Kim JJ, Canfell K, de Kok I, Barnabas RV, Kulasingam S. State-level disparities in cervical cancer prevention and outcomes in the United States: a modeling study. J Natl Cancer Inst. 2025;117(4):737\u201346. https:\/\/doi.org\/10.1093\/jnci\/djae298.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"29368_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12905-025-03841-w","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Fan Z, Wang J, Guan B, Zhou F, Tang Z, Wu W, Huang A. HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications. BMC Womens Health. 2025;25(1):285. https:\/\/doi.org\/10.1186\/s12905-025-03841-w.","journal-title":"BMC Womens Health"},{"key":"29368_CR50","doi-asserted-by":"publisher","first-page":"218286","DOI":"10.1016\/j.canlet.2026.218286","volume":"642","author":"M Yuan","year":"2026","unstructured":"Yuan M, Hong Y, Feng Y, Sun J, Zhao X, Hu S, Zhao F. Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening. Cancer Lett. 2026;642:218286. https:\/\/doi.org\/10.1016\/j.canlet.2026.218286.","journal-title":"Cancer Lett"},{"issue":"1","key":"29368_CR51","doi-asserted-by":"publisher","first-page":"2557092","DOI":"10.1080\/21645515.2025.2557092","volume":"21","author":"X Fu","year":"2025","unstructured":"Fu X, Zhang Q, Wagner AL, Zhou W, Xia Y, Lu Y. Cost-effectiveness and epidemiological impact of gender-neutral vaccination against human papillomavirus in economically developed metropolises of Beijing, Shanghai, and Guangzhou, China. Hum Vaccin Immunother. 2025;21(1):2557092. https:\/\/doi.org\/10.1080\/21645515.2025.2557092.","journal-title":"Hum Vaccin Immunother"},{"key":"29368_CR52","doi-asserted-by":"publisher","unstructured":"Zou Z, Fairley CK, Ong JJ, Shen M, Chow EPF, Liu H, Xia R, Li R, Hocking J, Zhuang G et al. Impact of achieving WHO\u2019s 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study. EClinicalMedicine. 2024;77:102878. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102878.","DOI":"10.1016\/j.eclinm.2024.102878"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-29368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-29368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-29368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:10:11Z","timestamp":1790237411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-29368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29368"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-29368-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study was conducted entirely with deidentified, aggregate, and publicly available data from the CI5 database; therefore, ethical approval and informed consent were not needed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2673"}}